Dap-ug, Jellfe E.
HRN: 22-12-30 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/30/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/30/2022
11/06/2022
IV
500mg
Q8hour
Acute Appendicitis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes